Economic Issues and Viability of Gene-Based Molecular Therapies for Cardiovascular Disease
Canadian Journal of Cardiology · 2026-05 · 42 (5) · 1047-1050
DOI: 10.1016/j.cjca.2026.03.004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Canadian Journal of Cardiology, 2026-05. Verfasst von Jakub Hlávka. Beteiligte Einrichtung: Health Economics, Policy, and Innovation Institute, Faculty of Economics and Administration, Masaryk University, Brno, Czech Republic. Electronic add…. Die Arbeit nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Commission, Ministry of Education Youth and Sports of the Czech Republic.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Health Economics, Policy, and Innovation Institute, Faculty of Economics and Administration, Masaryk University, Brno, Czech Republic. Electronic address: jakub.hlavka@econ.muni.cz.
Förderung
- European Commission
- Ministry of Education Youth and Sports of the Czech Republic
Zitieren
APA
Hlávka, J. (2026). Economic Issues and Viability of Gene-Based Molecular Therapies for Cardiovascular Disease. Canadian Journal of Cardiology, 42(5), 1047-1050. https://doi.org/10.1016/j.cjca.2026.03.004
Vancouver
Hlávka J. Economic Issues and Viability of Gene-Based Molecular Therapies for Cardiovascular Disease. Canadian Journal of Cardiology. 2026;42(5):1047-1050. doi:10.1016/j.cjca.2026.03.004
BibTeX
@article{Hlvka2026,
author = {Hlávka, Jakub},
title = {Economic Issues and Viability of Gene-Based Molecular Therapies for Cardiovascular Disease},
journal = {Canadian Journal of Cardiology},
year = {2026},
volume = {42},
number = {5},
pages = {1047--1050},
doi = {10.1016/j.cjca.2026.03.004}
}
EUVIMED